Outcomes

NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on the path to approval for its lead-product…

SB15 demonstrates comparable efficacy, safety, immunogenicity,…

The…

MUMBAI, India, March 6, 2023 /PRNewswire/ -- Fitterfly, a leading Indian health-tech company, working in the area of diabetes & metabolic health, recently showcased data from its Digital Therapeutics Technology platform at the 16th…

Industry-Leading initiative continues to provide opportunities for clients and agencies to engage with diversely-owned media partners NEW YORK--(BUSINESS WIRE)--MAGNA, the investment and intelligence company of IPG Mediabrands, today…

NEW DELHI, Jan. 25, 2023 /PRNewswire/ -- Cloud-based HCM Platform, ZingHR in its endeavour to move into a New Era of Customer Experience, and carve out a unique position, organised three mega concurrent Pitstop events across Delhi,…

– Kite’s Manufacturing Time for Yescarta® in the U.S. is Median of 7-Days from Start of Cell Enrichment to Harvest, with an Overall 16-Day Turnaround Time (Leukapheresis to Product Release) – – CIBMTR Analysis Finds Median…

Single-cell RNA sequencing of reticulocytes will be used to measure gene correction outcomes in sickle cell patients treated with nulabeglogene autogedtemcel (nula-cel) SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Graphite Bio, Inc.…

- Cryopreserved, Post-thaw CAR T Cell Composition and Effective CAR T Cell Dose are Predictive for Response to Treatment with Azer-cel - Peak CAR T Expansion, a Key Determinant of Durable Response, Strongly Correlated with Effective…

SALT LAKE CITY, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today presented results from a longitudinal study validating RiskScore as a well-calibrated…